FDA Approves CELECOXIB — Unichem Pharmaceuticals (USA), Inc.

Unichem Pharmaceuticals (USA), Inc. received FDA approval for its oral Celecoxib ANDA on January 12, 2021, adding a generic entry to the cardiovascular manufacturer’s portfolio. This approval strengthens its market presence amidst U.S. patent expirations while contributing to ongoing competition in the widely prescribed NSAID class.